1McCarthy DM,Maitra A,Argani P,et al.Novel markers of pancreatic adenocarcinoma in fine-needle aspiration:mesothelin and prostate stem cell antigen labeling increases accuracy in cytologically borderline cases.Applied Immunobistochem Mol Morphol,2003,11:238-243.
2Argani P,Iacobuzio-Donahue C,Ryu B,et al.Mesothelin is overexpressed in the vest majority of ductal adenocarcinomas of the pancreas:identification of a new pancreatic cancer marker by serial analysis of gene expression(SAGE).Clin Cancer Res,2001,7:3862-3868.
3Argani P,Rosty C,Reiter RE,et al.Discovery of new markers of cancer through serial analysis of gene expression:prostate stem cell antigen is overexpressed in pancreatic adenocarcinoma.Cancer Res,2001,61:4320-4324.
4Koopmann J,Fedarko NS,Jain A,et al.Evaluation of osteopontin as biomarker for pancreatic adenocarcinoma.Cancer Epidemiol Biomarkers Prev,2004,13:487-491.
5Yantiss RK,Woda BA,Fanger GR,et al.KOC(K homology domain containing protein overexpressed in cancer):a novel molecular marker that distinguishes between benign and malignant lesions of the pancreas.Am J Surg Pathol,2005,29:188-195.
6Crnogorac-Jurcevic T,Missiaglia E,Blaveri E,et al.Molecular alterations in pancreatic carcinoma:expression profiling shows that dystregulated expression of S100 genes is highly prevalent.J Pathol,2003,201,63-74.
7Dowen SE,Crnogorac-Jurcevic T,Gangeswaran R,et al.Expression of S100P and its novel binding partner S100PBPR in early pancreatic cancer.Am J Pathol,2005,166:81-92.
8Ventrucci M,Cipolla A,Racchini C,et al.Tumor M2-pyruvate kinase,a new metabolic marker for pancreatic cancer.Dig Dis Sci,2004,49:1149-1155.
9吴东,钱家鸣.血浆中弹力蛋白酶1在胰腺癌诊断中意义.待发表.
10Sawabu N,Watanabe H,Yamaguchi Y,et al.Serum tumor markers and molecular biological diagnosis in pancreatic cancer.Pancreas,2004,28:263-267.
二级参考文献19
1Celis JE;Wolf H;Qstergaard M.Bladder squamous cellcarcinoma biomarkers derived from proteomics[J],2000(11).
2Simpson RJ;Dorow DS.Cancer proteomics: from signalling networks to tumor markers[J],2001(10).
3Harris RA;Yang A;Stein RC.Cluster analysis of an extensive human breast cancer cell line protein expression map datebase[J],2002(02).
4Bichsel VE;Liotta LA;Petricoin EF 3rd.Cancer proteomics: from biomarker discovery to signal pathway profiling,2001(01).
5Alaiya AA;Franzen B;Auer G.Cancer proteomics:from identification of novel markers to creation of artificial learning models for tumor classification[J],2000(06).
6Sauter ER;Zhu W;Fan XJ.Proteomic analysis of nipple aspirate fluid to detect biologic markers of breast cancer[J],2002(09).
7Luftner D;Possinger K.Nuclear matrix proteins as biomarkers for breast cancer,2002(01).
8Vlahou A;Schellhammer PF;Mendrinos S.Development of a novel proteomic approach for the detection of transistional cell carcinoma of the bladder in urine[J],2001(04).
9Bubendorf L;Kolmer M;Kononen J.Hormone therapy falure in human prostate cancer: analysis by complementary DNA and tissue microarrays[J],1999(20).
10Moch H;Schraml P;Bubendprf L.High-throughput tissue microarray analysis to evaluate genes uncovered by cDNA microarray sereening in renal cell carcinoma,1999(04).
